What exactly changed in the Feb 04, 2026 Scotiabank note on Kinaxis

On Feb 04, 2026 Scotiabank maintained an **Outperform** on Kinaxis but cut the price target from **C$240** to **C$200**. The update left the rating unchanged while lowering projected upside and led to a **-1.37% (-$1.24)** price reaction

How should I interpret the KXSCF analyst rating now

A maintained Outperform with a lower price target signals continued confidence with reduced upside. Treat the **KXSCF analyst rating** as supportive for long-term holders but as a caution for traders seeking quick gains

Does the note affect Kinaxis valuation or market cap

Yes. The target cut narrows implied upside and can pressure multiples. Kinaxis's market cap stands at **$2,539,566,942**, and investors should reassess valuation versus peers after the Scotiabank update

Where can I find the original note and further coverage

The Scotiabank price target change is summarized by TheFly. See the report here [source](https://thefly.com/permalinks/entry.php/id4284978/2061286394/KXSCF-Kinaxis-price-target-lowered-by-C-at-Scotiabank). For live tracking visit the Meyka stock page for KXSCF [Meyka KXSCF page](https://meyka.ai/sts

Analyst Ratings

Scotiabank Maintains Outperform for Kinaxis (KXSCF) Feb 04 2026 PT C$200

ByHuzaifa Zahoor February 5, 2026February 5, 2026

On February 04, 2026 at 11:09 AM Scotiabank maintained an Outperform on Kinaxis Inc. and lowered its price target to C$200 from C$240. The KXSCF analyst rating update signals continued confidence in long-term prospects while trimming near-term upside. Scotiabank left the rating unchanged but signaled more conservative assumptions. Meyka AI rates KXSCF with a grade of B+. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus, and is not financial advice